000 | 01895 a2200493 4500 | ||
---|---|---|---|
005 | 20250518034654.0 | ||
264 | 0 | _c20190812 | |
008 | 201908s 0 0 eng d | ||
022 | _a1365-2613 | ||
024 | 7 |
_a10.1111/iep.12312 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKarpov, Andrey A | |
245 | 0 | 0 |
_aNon-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells. _h[electronic resource] |
260 |
_bInternational journal of experimental pathology _c04 2019 |
||
300 |
_a102-113 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAlginates |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xetiology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCicatrix _xpathology |
650 | 0 | 4 |
_aCytoprotection _xphysiology |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 | _aImmunophenotyping |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xphysiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesenchymal Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 |
_aMesenchymal Stem Cells _ximmunology |
650 | 0 | 4 |
_aMyocardial Infarction _xdiagnostic imaging |
650 | 0 | 4 |
_aParacrine Communication _xphysiology |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aVentricular Function, Left _xphysiology |
650 | 0 | 4 |
_aVentricular Remodeling _xphysiology |
700 | 1 | _aPuzanov, Maxim V | |
700 | 1 | _aIvkin, Dmitry Yu | |
700 | 1 | _aKrasnova, Marina V | |
700 | 1 | _aAnikin, Nikita A | |
700 | 1 | _aDocshin, Pavel M | |
700 | 1 | _aMoiseeva, Olga M | |
700 | 1 | _aGalagudza, Michael M | |
773 | 0 |
_tInternational journal of experimental pathology _gvol. 100 _gno. 2 _gp. 102-113 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/iep.12312 _zAvailable from publisher's website |
999 |
_c29620269 _d29620269 |